Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome

Published:2020-04-15 Issue:8 Volume:59 Page:1081-1086
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hashimoto Miki¹,Itonaga Hidehiro²,Nannya Yasuhito³,Taniguchi Hirokazu⁴,Fukuda Yuichi⁵,Furumoto Takafumi⁶,Fujioka Machiko¹⁷,Kasai Sachie¹,Taguchi Masataka⁷,Taniguchi Hiroaki⁶,Sato Shinya⁷,Sawayama Yasushi⁷,Atogami Sunao⁸,Iwasaki Keisuke⁹,Hata Tomoko²,Soda Hiroshi⁵,Moriuchi Yukiyoshi⁶,Nakata Koh¹⁰,Ogawa Seishi³,Miyazaki Yasushi¹²⁷

Affiliation:

1. Department of Hematology, Nagasaki University Graduate School of Biomedical Sciences, Japan

2. Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Japan

3. Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan

4. Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan

5. Department of Respiratory Medicine, Sasebo City General Hospital, Japan

6. Department of Hematology, Sasebo City General Hospital, Japan

7. Department of Hematology, Nagasaki University Hospital, Japan

8. Department of Clinical Laboratory, Sasebo City General Hospital, Japan

9. Department of Pathology, Sasebo City General Hospital, Japan

10. Bioscience Medical Research Center, Niigata University Medical and Dental Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/8/59_3770-19/_pdf

Reference31 articles.

1. 1. Rosen SH, Castleman B, Liebow AA, Enzinger FM, Hunt RTN. Pulmonary alveolar proteinosis. N Engl J Med 258: 1123-1142, 1958.

2. 2. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 190: 875-880, 1999.

3. 3. Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123: 809-821, 2014.

4. 4. Griese M, Zarbock R, Costabel U, et al. GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders. BMC Pulm Med 15: 87, 2015.

5. 5. Ishii H, Tazawa R, Kaneko C, et al. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan. Eur Respir J 37: 465-468, 2011.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation;International Journal of Hematology;2023-04-21

2. Pulmonale Alveolarproteinose;Seltene Lungenerkrankungen;2022

3. Intestinal Behçet’s disease complicated by myelodysplastic syndrome and secondary pulmonary alveolar proteinosis: a case report;BMC Gastroenterology;2021-12

4. Knowledge of Secondary Pulmonary Alveolar Proteinosis Complicated with Myelodysplastic Syndrome;Internal Medicine;2020-04-15